Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]
<p>Abstract</p> <p>Background</p> <p>The combination therapies recommended by the World Health Organization for treatment of brucellosis are doxycycline plus rifampicin or doxycycline plus streptomycin. Although highly successful results have been obtained with these tw...
Main Authors: | Kayas Derya, Sencan Irfan, Karabay Oguz, Şahin Idris |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-06-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2334/4/18 |
Similar Items
-
Clinical Effect of Doxycycline Combined with Compound Sulfamethoxazole and Rifampicin in the Treatment of Brucellosis Spondylitis
by: Yang XM, et al.
Published: (2021-11-01) -
Doxycycline Plus Trimethoprim-Sulfamethoxazole versus Doxycycline plus Rifampicin in Treatment of Brucellosis: A Randomized Controlled Trial
by: Waleed A Hassan, et al.
Published: (2022-01-01) -
Development and Validation of HPLC method for simultaneous estimation of Rifampicin and Ofloxacin using experimental design
by: Purvi Shah, et al.
Published: (2019-12-01) -
Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis
by: Xiang Li, et al.
Published: (2022-10-01) -
Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis
by: MRH Roushan, et al.
Published: (2004-09-01)